生検装置市場：製品、技術、用途、エンドユーザー別 - 2024年～2030年の世界予測

生検装置市場規模は、2023年に94億7,000万米ドルと推定され、2024年には104億6,000万米ドルに達し、CAGR 10.82%で2030年には194億6,000万米ドルに達すると予測されています。

生検装置は、疾患の存在や程度を特定することを目的とした検査のために、サンプルの細胞や組織を抽出する診断手順で明確に使用されます。これらの機器は、針、生検ガイダンスシステム、生検鉗子など多岐にわたる。生検装置は、乳房生検、消化管生検、前立腺生検、肝生検、肺生検など、疾患の検出やモニタリングに関連するいくつかの医療用途において重要な役割を担っています。世界のがん罹患率の増加と低侵襲手術への嗜好の高まりが市場成長を促進する極めて重要な要因です。対照的に、高い機器コスト、生検手技に伴うリスク、医療当局による厳しい規制ハードルが市場成長の妨げとなっています。しかし、複数のベンダーがこれらの問題を克服するために研究開発に注力しています。さらに、生検装置の製造工程における進歩、研究や組織バンクにおける生検装置の使用拡大、ヘルスケアインフラの改善、新興国への投資などが市場拡大に寄与しています。

製品合併症のリスクが最小限に抑えられるため、針を使用する生検器具への嗜好が高まる

生検鉗子は、低侵襲手技の際に使用される洗練された手持ち式の器具であり、2枚の葉で構成された構造になっています。ローカリゼーションワイヤーは、特に乳房生検手技において、生検の正しい部位を特定するためのガイドとして機能します。マンモグラフィや超音波検査で検出された触知不能な病変を分離するために術前に使用され、精度を確保し、放射線科医が組織標本を採取する際の助けとなります。深在性病変には針生検装置が好まれ、一般的なタイプとしては、細針吸引法やコアニードル生検法があります。これらの器具は手技の合併症を減らし、高品質のサンプルを効率よく採取できることで知られており、正確な診断に役立っています。針を使用する生検器具には、吸引針、コア生検生検装置、バキュームアシスト生検生検装置があります。吸引針は、しこりや腫瘤を調べるために使用される細針吸引生検で重要な役割を果たします。コア生検装置は、病理検査のために小さな組織切片を摘出するもので、通常、乳房、肝臓、骨生検に用いられます。バキュームアシスト型テーマは、低侵襲生検手技のための非常に効率的なツールです。真空機構を採用したこの装置は、針を刺し直すことなく連続的に組織サンプルを採取することができます。プロシージャー・トレイは、特定の手技に必要な生検器具をすべて網羅したコンパクトで体系的なソリューションです。ワークフローを最適化し、リソースの効率的な利用を促進し、手技の無菌性を高めます。

手技高い診断精度を実現する生検装置におけるMRIガイド下生検の重要な役割

画像誘導生検は、現代の画像技術の精度を活用した、生検装置の領域における注目すべき技術革新です。この高度な技術により、医師はアクセス困難な部位からサンプルを採取することができ、より正確で侵襲の少ない処置が可能となります。画像ガイド下生検には、MRIガイド下生検、定位ガイド下生検、超音波ガイド下生検があります。MRIガイド下生検は、到達困難な部位や、脳や乳房などのより複雑な構造の異常の診断に適した手技となっています。定位ガイド下生検は、乳房や皮膚に近い病変など、比較的表在性の異常に適用しやすいです。この手技は患者にとって、侵襲的な処置の不快感を避けつつ、精度の高い診断を確実に行えるという利点があります。超音波ガイド下生検は、主にリアルタイムの画像提供という利点を生かし、頸部、胸部、腹部の生検に最適な選択肢となっています。さらに、超音波ガイド下生検は費用対効果に優れ、より迅速に生検を行うことができるため、費用と時間を第一に考慮しなければならない状況で好まれています。これと比較して、MRIガイド下生検は高度な症例の最前線に立ち、定位生検リングは表在性の症例に必要であり、超音波ガイド下生検はリアルタイムの要件と費用対効果のシナリオにおいて有益であることが証明されています。非画像ガイド下生検には、触診や解剖学的ランドマークを用いて生検部位を決定する手技が含まれ、実画像ガイドの助けは必要ないです。画像ガイド下生検と非画像ガイド下生検のどちらを選択するかは、病変の位置や性質、患者の健康状態、利用可能なリソースに大きく依存します。画像ガイド下生検法は、特に非触知病変や深在性病変に対して、精度と安全性の観点から有力です。しかし、表在性の腫瘤に対しては、非画像ガイド下生検法が依然として迅速で費用対効果の高い選択肢です。

応用乳がんおよび前立腺がんに対するニーズの高まり生検装置両領域におけるがん罹患率の増加によるもの

世界の乳がん患者の増加により、乳腺生検装置のニーズが高まっています。真空補助下生検（VAB）システムのような装置は、低侵襲性、確実な診断、高速で痛みのないプロセスで支持を得ています。軟性S状結腸鏡は、直腸やS状結腸の異常を検出できるため、大腸生検に好まれています。がんを含む肺疾患の罹患率の増加は、経胸壁針生検（TTNB）装置が一般的に使用される肺生検装置の必要性を誘発します。前立腺生検では、経直腸的超音波（TRUS）ガイド下前立腺生検の生検装置が主に使用されています。乳房および前立腺生検の生検装置は、がん罹患率の上昇に伴い、著しい技術進歩を遂げています。同時に、肺生検や大腸生検用の機器は、がんを含むさまざまな疾患に対応しています。生検装置は医療診断において最も重要であり、継続的な進歩を反映し、患者の健康を確保します。

エンドユーザー：病院での回復時間の短縮を促進する生検装置の利用増加

学術・研究機関では、生検手技の精度と効率を向上させる革新的なソリューションを追求しており、特に非侵襲的手技に重点を置いています。これらの研究機関は、医学研究の新たなフロンティアを開拓できる高度で先進的な生検装置を求めています。診断センターおよび画像診断センターは、タイムリーで正確な診断に主眼を置いています。これらの施設では、患者の不快感を最小限に抑え、迅速なサンプル採取を可能にする生検装置を必要としています。回復時間の短縮、合併症の減少、コストの削減を可能にする生検装置は、主に患者の安全性、快適性、費用対効果を重視するプライマリーヘルスケアプロバイダーや病院が理想とするものです。これらのユーザーグループに共通する目的は、生検手技の精度と効率を高めることです。多様なセクターが市場の進化を促進する必要があり、より繊細なイノベーションと世界の健康アウトカムの改善が期待されます。

地域別洞察

南北アメリカ地域では、さまざまながん患者の増加により、生検装置の利用が増加傾向にあります。米国がん協会によると、2023年には1,958,310人の新規がん患者が発生すると推定されています。これが生検装置の必要性に直結しています。最先端技術と医療の進歩は、この地域における有利な償還政策とともに、市場成長に寄与しています。また、強力なヘルスケアマーケティングによって強化されたがんの早期発見に関する意識の高まりが、この地域での生検装置の使用増加に道を開いています。さらに、急速に高齢化が進み、がんの罹患率が高いという特徴を持つEMEA地域では、生検装置に対するニーズが高いです。市場流入の背景には、技術的に進歩したヘルスケア機器やインフラの導入もあります。この地域の国家ヘルスケアシステムはタイムリーで正確ながん診断を促進し、生検装置の利用拡大を可能にしています。世界保健機関（WHO）と欧州腫瘍学研究所（European Institute of Oncology）による啓発キャンペーンが、この地域における生検装置の必要性を刺激しています。さらに、APAC地域ではがんを含む生活習慣病が急増しています。高齢化、環境汚染、不健康な生活習慣ががんの発生を助長し、生検装置の必要性を高めています。さらに、ヘルスケアシステムの改善、医療費の増加、がんの早期発見に関する意識の向上なども、生検装置の採用を促進する要因となっています。

FPNVポジショニング・マトリックス

FPNVポジショニングマトリックスは、生検装置市場の評価において極めて重要です。事業戦略や製品満足度に関連する主要指標を調査し、ベンダーの包括的な評価を提供します。この綿密な分析により、ユーザーは各自の要件に沿った十分な情報に基づいた意思決定を行うことができます。評価に基づき、ベンダーは成功の度合いが異なる4つの象限に分類されます：フォアフロント（F）、パスファインダー（P）、ニッチ（N）、バイタル（V）です。

市場シェア分析

市場シェア分析は、生検装置市場におけるベンダーの現状について、洞察に満ちた詳細な調査を提供する包括的なツールです。全体的な収益、顧客基盤、その他の主要指標についてベンダーの貢献度を綿密に比較・分析することで、企業の業績や市場シェア争いの際に直面する課題について理解を深めることができます。さらに、この分析により、調査対象基準年に観察された累積、断片化の優位性、合併の特徴などの要因を含む、この分野の競合特性に関する貴重な考察が得られます。このような詳細レベルの拡大により、ベンダーはより多くの情報に基づいた意思決定を行い、市場で競争優位に立つための効果的な戦略を考案することができます。

本レポートは、以下の側面に関する貴重な洞察を提供しています：

1.市場の浸透度：主要企業が提供する市場に関する包括的な情報を提示しています。

2.市場の開拓度：有利な新興市場を深く掘り下げ、成熟市場セグメントにおける浸透度を分析しています。

3.市場の多様化：新製品の発売、未開拓の地域、最近の開発、投資に関する詳細な情報を提供します。

4.競合の評価と情報：市場シェア、戦略、製品、認証、規制状況、特許状況、主要企業の製造能力などを網羅的に評価します。

5.製品開発およびイノベーション：将来の技術、研究開発活動、画期的な製品開発に関する知的洞察を提供します。

本レポートは、以下のような主要な質問に対応しています：

1.生検装置市場の市場規模および予測は？

2.生検装置市場の予測期間中に投資を検討すべき製品、セグメント、用途、分野は何か？

3.生検装置市場の技術動向と規制枠組みは？

4.生検装置市場における主要ベンダーの市場シェアは？

5.生検装置市場への参入に適した形態や戦略的手段は？

目次

第1章 序文

第2章 調査手法

第3章 エグゼクティブサマリー

第4章 市場の概要

第5章 市場洞察

• 市場力学
  • 促進要因
    • がんや胃腸疾患の発生率増加
    • 低侵襲技術の採用の増加
    • 病気の早期発見とスクリーニングの重要性に対する認識の高まり
  • 抑制要因
    • 生検装置の制作にかかるコストが高い
  • 機会
    • 生検装置における継続的な技術進歩
    • 流動性への傾向の高まり生検装置
  • 課題
    • 保健当局による厳格な規制に伴う問題
• 市場セグメンテーション分析
  • 製品：合併症のリスクが最小限であるため、針ベースの生検器具が好まれる傾向が高まっています。
  • 技術：高い診断精度を実現する生検装置におけるMRI誘導生検の重要な役割
  • 用途：乳がんと前立腺がんの両方の症例が増加しているため、乳がんと前立腺がんの需要が高まっています。
  • エンドユーザー：病院での回復時間の短縮を促進する生検装置の利用率の向上
• 市場動向分析
  • 南北アメリカ地域における大手企業の強力なプレゼンスと相まって、新規生検装置の開発に向けた調査活動が活発化している
  • 地域の規制当局による製品承認の増加と研究開発活動の拡大により、APAC地域で生検装置の適用が拡大
  • EMEA地域における先進的なヘルスケア施設とがん検出・予防プログラム
• 高インフレの累積的影響
• ポーターのファイブフォース分析
• バリューチェーンとクリティカルパス分析
• 規制枠組みの分析

第6章 生検装置市場：製品別

• 生検鉗子
• ローカリゼーションワイヤー
• 針式生検器具
• 処置トレイ

第7章 生検装置市場：技術別

• 画像誘導生検
• 非画像誘導生検

第8章 生検装置市場：用途別

• 骨髄生検
• 乳房生検
• 腎臓生検
• 肺生検
• 前立腺生検

第9章 生検装置市場：エンドユーザー別

• 学術研究機関
• 診断・画像診断センター
• 病院

第10章 南北アメリカの生検装置市場

• アルゼンチン
• ブラジル
• カナダ
• メキシコ
• 米国

第11章 アジア太平洋の生検装置市場

• オーストラリア
• 中国
• インド
• インドネシア
• 日本
• マレーシア
• フィリピン
• シンガポール
• 韓国
• 台湾
• タイ
• ベトナム

第12章 欧州・中東・アフリカの生検装置市場

• デンマーク
• エジプト
• フィンランド
• フランス
• ドイツ
• イスラエル
• イタリア
• オランダ
• ナイジェリア
• ノルウェー
• ポーランド
• カタール
• ロシア
• サウジアラビア
• 南アフリカ
• スペイン
• スウェーデン
• スイス
• トルコ
• アラブ首長国連邦
• 英国

第13章 競合情勢

• 市場シェア分析、2023年
• FPNVポジショニングマトリックス、2023年
• 競合シナリオ分析
  • LUMINELLE、中国国家知識産権局によるLUMINELLE Bx（生検）システムの特許発行決定を発表、世界展開を拡大
  • リマカ・メディカル、画期的な精密消化管内視鏡生検装置でFDA 510（k）認可を取得
  • ストライカー、頭蓋誘導ソフトウェアを搭載したQガイダンスシステムの商業発売を発表
  • メリットメディカル、アンジオダイナミクスのカテーテルポートフォリオと生検システムを買収
  • アルゴンのSuperCore Advantage生検装置が米国で発売
  • クエスト・ダイアグノスティクスがヘイスタック・オンコロジーを買収、腫瘍学ポートフォリオに個別化がん治療の改善に向けた高感度液体生検技術を追加
  • Innovia Medical、BACO International 2023で口腔回転式生検パンチを発表
  • Guardant360 CDxがORSERDUのコンパニオン診断薬としてFDAの承認を取得
  • TransMed7 LLC、SpeedBird Breast生検装置の商業発売に向けた初の臨床使用を発表
  • テルモ・インド、ポートフォリオ拡大のためアルゴン・メディカルと提携

第14章 競合ポートフォリオ

• 主要企業プロファイル
• 主要製品ポートフォリオ

LIST OF FIGURES

• FIGURE 1. BIOPSY DEVICES MARKET RESEARCH PROCESS
• FIGURE 2. BIOPSY DEVICES MARKET SIZE, 2023 VS 2030
• FIGURE 3. GLOBAL BIOPSY DEVICES MARKET SIZE, 2018-2030 (USD MILLION)
• FIGURE 4. GLOBAL BIOPSY DEVICES MARKET SIZE, BY REGION, 2023 VS 2030 (%)
• FIGURE 5. GLOBAL BIOPSY DEVICES MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 6. BIOPSY DEVICES MARKET DYNAMICS
• FIGURE 7. GLOBAL BIOPSY DEVICES MARKET SIZE, BY PRODUCT, 2023 VS 2030 (%)
• FIGURE 8. GLOBAL BIOPSY DEVICES MARKET SIZE, BY PRODUCT, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 9. GLOBAL BIOPSY DEVICES MARKET SIZE, BY TECHNIQUE, 2023 VS 2030 (%)
• FIGURE 10. GLOBAL BIOPSY DEVICES MARKET SIZE, BY TECHNIQUE, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 11. GLOBAL BIOPSY DEVICES MARKET SIZE, BY APPLICATION, 2023 VS 2030 (%)
• FIGURE 12. GLOBAL BIOPSY DEVICES MARKET SIZE, BY APPLICATION, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 13. GLOBAL BIOPSY DEVICES MARKET SIZE, BY END USER, 2023 VS 2030 (%)
• FIGURE 14. GLOBAL BIOPSY DEVICES MARKET SIZE, BY END USER, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 15. AMERICAS BIOPSY DEVICES MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
• FIGURE 16. AMERICAS BIOPSY DEVICES MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 17. UNITED STATES BIOPSY DEVICES MARKET SIZE, BY STATE, 2023 VS 2030 (%)
• FIGURE 18. UNITED STATES BIOPSY DEVICES MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 19. ASIA-PACIFIC BIOPSY DEVICES MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
• FIGURE 20. ASIA-PACIFIC BIOPSY DEVICES MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 21. EUROPE, MIDDLE EAST & AFRICA BIOPSY DEVICES MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
• FIGURE 22. EUROPE, MIDDLE EAST & AFRICA BIOPSY DEVICES MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 23. BIOPSY DEVICES MARKET SHARE, BY KEY PLAYER, 2023
• FIGURE 24. BIOPSY DEVICES MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

• TABLE 1. BIOPSY DEVICES MARKET SEGMENTATION & COVERAGE
• TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
• TABLE 3. GLOBAL BIOPSY DEVICES MARKET SIZE, 2018-2023 (USD MILLION)
• TABLE 4. GLOBAL BIOPSY DEVICES MARKET SIZE, 2024-2030 (USD MILLION)
• TABLE 5. GLOBAL BIOPSY DEVICES MARKET SIZE, BY REGION, 2018-2023 (USD MILLION)
• TABLE 6. GLOBAL BIOPSY DEVICES MARKET SIZE, BY REGION, 2024-2030 (USD MILLION)
• TABLE 7. GLOBAL BIOPSY DEVICES MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
• TABLE 8. GLOBAL BIOPSY DEVICES MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
• TABLE 9. GLOBAL BIOPSY DEVICES MARKET SIZE, BY BIOPSY FORCEPS, BY REGION, 2018-2023 (USD MILLION)
• TABLE 10. GLOBAL BIOPSY DEVICES MARKET SIZE, BY BIOPSY FORCEPS, BY REGION, 2024-2030 (USD MILLION)
• TABLE 11. GLOBAL BIOPSY DEVICES MARKET SIZE, BY LOCALIZATION WIRES, BY REGION, 2018-2023 (USD MILLION)
• TABLE 12. GLOBAL BIOPSY DEVICES MARKET SIZE, BY LOCALIZATION WIRES, BY REGION, 2024-2030 (USD MILLION)
• TABLE 13. GLOBAL BIOPSY DEVICES MARKET SIZE, BY NEEDLE-BASED BIOPSY INSTRUMENTS, BY REGION, 2018-2023 (USD MILLION)
• TABLE 14. GLOBAL BIOPSY DEVICES MARKET SIZE, BY NEEDLE-BASED BIOPSY INSTRUMENTS, BY REGION, 2024-2030 (USD MILLION)
• TABLE 15. GLOBAL BIOPSY DEVICES MARKET SIZE, BY NEEDLE-BASED BIOPSY INSTRUMENTS, 2018-2023 (USD MILLION)
• TABLE 16. GLOBAL BIOPSY DEVICES MARKET SIZE, BY NEEDLE-BASED BIOPSY INSTRUMENTS, 2024-2030 (USD MILLION)
• TABLE 17. GLOBAL BIOPSY DEVICES MARKET SIZE, BY ASPIRATION NEEDLES, BY REGION, 2018-2023 (USD MILLION)
• TABLE 18. GLOBAL BIOPSY DEVICES MARKET SIZE, BY ASPIRATION NEEDLES, BY REGION, 2024-2030 (USD MILLION)
• TABLE 19. GLOBAL BIOPSY DEVICES MARKET SIZE, BY CORE BIOPSY DEVICES, BY REGION, 2018-2023 (USD MILLION)
• TABLE 20. GLOBAL BIOPSY DEVICES MARKET SIZE, BY CORE BIOPSY DEVICES, BY REGION, 2024-2030 (USD MILLION)
• TABLE 21. GLOBAL BIOPSY DEVICES MARKET SIZE, BY VACUUM-ASSISTED BIOPSY DEVICES, BY REGION, 2018-2023 (USD MILLION)
• TABLE 22. GLOBAL BIOPSY DEVICES MARKET SIZE, BY VACUUM-ASSISTED BIOPSY DEVICES, BY REGION, 2024-2030 (USD MILLION)
• TABLE 23. GLOBAL BIOPSY DEVICES MARKET SIZE, BY PROCEDURE TRAYS, BY REGION, 2018-2023 (USD MILLION)
• TABLE 24. GLOBAL BIOPSY DEVICES MARKET SIZE, BY PROCEDURE TRAYS, BY REGION, 2024-2030 (USD MILLION)
• TABLE 25. GLOBAL BIOPSY DEVICES MARKET SIZE, BY TECHNIQUE, 2018-2023 (USD MILLION)
• TABLE 26. GLOBAL BIOPSY DEVICES MARKET SIZE, BY TECHNIQUE, 2024-2030 (USD MILLION)
• TABLE 27. GLOBAL BIOPSY DEVICES MARKET SIZE, BY IMAGE GUIDED BIOPSY, BY REGION, 2018-2023 (USD MILLION)
• TABLE 28. GLOBAL BIOPSY DEVICES MARKET SIZE, BY IMAGE GUIDED BIOPSY, BY REGION, 2024-2030 (USD MILLION)
• TABLE 29. GLOBAL BIOPSY DEVICES MARKET SIZE, BY IMAGE GUIDED BIOPSY, 2018-2023 (USD MILLION)
• TABLE 30. GLOBAL BIOPSY DEVICES MARKET SIZE, BY IMAGE GUIDED BIOPSY, 2024-2030 (USD MILLION)
• TABLE 31. GLOBAL BIOPSY DEVICES MARKET SIZE, BY MRI-GUIDED BIOPSY, BY REGION, 2018-2023 (USD MILLION)
• TABLE 32. GLOBAL BIOPSY DEVICES MARKET SIZE, BY MRI-GUIDED BIOPSY, BY REGION, 2024-2030 (USD MILLION)
• TABLE 33. GLOBAL BIOPSY DEVICES MARKET SIZE, BY STEREOTACTIC-GUIDED BIOPSY, BY REGION, 2018-2023 (USD MILLION)
• TABLE 34. GLOBAL BIOPSY DEVICES MARKET SIZE, BY STEREOTACTIC-GUIDED BIOPSY, BY REGION, 2024-2030 (USD MILLION)
• TABLE 35. GLOBAL BIOPSY DEVICES MARKET SIZE, BY ULTRASOUND-GUIDED BIOPSY, BY REGION, 2018-2023 (USD MILLION)
• TABLE 36. GLOBAL BIOPSY DEVICES MARKET SIZE, BY ULTRASOUND-GUIDED BIOPSY, BY REGION, 2024-2030 (USD MILLION)
• TABLE 37. GLOBAL BIOPSY DEVICES MARKET SIZE, BY NON-IMAGE GUIDED BIOPSY, BY REGION, 2018-2023 (USD MILLION)
• TABLE 38. GLOBAL BIOPSY DEVICES MARKET SIZE, BY NON-IMAGE GUIDED BIOPSY, BY REGION, 2024-2030 (USD MILLION)
• TABLE 39. GLOBAL BIOPSY DEVICES MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
• TABLE 40. GLOBAL BIOPSY DEVICES MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
• TABLE 41. GLOBAL BIOPSY DEVICES MARKET SIZE, BY BONE MARROW BIOPSY, BY REGION, 2018-2023 (USD MILLION)
• TABLE 42. GLOBAL BIOPSY DEVICES MARKET SIZE, BY BONE MARROW BIOPSY, BY REGION, 2024-2030 (USD MILLION)
• TABLE 43. GLOBAL BIOPSY DEVICES MARKET SIZE, BY BREAST BIOPSY, BY REGION, 2018-2023 (USD MILLION)
• TABLE 44. GLOBAL BIOPSY DEVICES MARKET SIZE, BY BREAST BIOPSY, BY REGION, 2024-2030 (USD MILLION)
• TABLE 45. GLOBAL BIOPSY DEVICES MARKET SIZE, BY KIDNEY BIOPSY, BY REGION, 2018-2023 (USD MILLION)
• TABLE 46. GLOBAL BIOPSY DEVICES MARKET SIZE, BY KIDNEY BIOPSY, BY REGION, 2024-2030 (USD MILLION)
• TABLE 47. GLOBAL BIOPSY DEVICES MARKET SIZE, BY LUNG BIOPSY, BY REGION, 2018-2023 (USD MILLION)
• TABLE 48. GLOBAL BIOPSY DEVICES MARKET SIZE, BY LUNG BIOPSY, BY REGION, 2024-2030 (USD MILLION)
• TABLE 49. GLOBAL BIOPSY DEVICES MARKET SIZE, BY PROSTATE BIOPSY, BY REGION, 2018-2023 (USD MILLION)
• TABLE 50. GLOBAL BIOPSY DEVICES MARKET SIZE, BY PROSTATE BIOPSY, BY REGION, 2024-2030 (USD MILLION)
• TABLE 51. GLOBAL BIOPSY DEVICES MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
• TABLE 52. GLOBAL BIOPSY DEVICES MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
• TABLE 53. GLOBAL BIOPSY DEVICES MARKET SIZE, BY ACADEMIC & RESEARCH INSTITUTES, BY REGION, 2018-2023 (USD MILLION)
• TABLE 54. GLOBAL BIOPSY DEVICES MARKET SIZE, BY ACADEMIC & RESEARCH INSTITUTES, BY REGION, 2024-2030 (USD MILLION)
• TABLE 55. GLOBAL BIOPSY DEVICES MARKET SIZE, BY DIAGNOSTIC & IMAGING CENTERS, BY REGION, 2018-2023 (USD MILLION)
• TABLE 56. GLOBAL BIOPSY DEVICES MARKET SIZE, BY DIAGNOSTIC & IMAGING CENTERS, BY REGION, 2024-2030 (USD MILLION)
• TABLE 57. GLOBAL BIOPSY DEVICES MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2023 (USD MILLION)
• TABLE 58. GLOBAL BIOPSY DEVICES MARKET SIZE, BY HOSPITALS, BY REGION, 2024-2030 (USD MILLION)
• TABLE 59. AMERICAS BIOPSY DEVICES MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
• TABLE 60. AMERICAS BIOPSY DEVICES MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
• TABLE 61. AMERICAS BIOPSY DEVICES MARKET SIZE, BY NEEDLE-BASED BIOPSY INSTRUMENTS, 2018-2023 (USD MILLION)
• TABLE 62. AMERICAS BIOPSY DEVICES MARKET SIZE, BY NEEDLE-BASED BIOPSY INSTRUMENTS, 2024-2030 (USD MILLION)
• TABLE 63. AMERICAS BIOPSY DEVICES MARKET SIZE, BY TECHNIQUE, 2018-2023 (USD MILLION)
• TABLE 64. AMERICAS BIOPSY DEVICES MARKET SIZE, BY TECHNIQUE, 2024-2030 (USD MILLION)
• TABLE 65. AMERICAS BIOPSY DEVICES MARKET SIZE, BY IMAGE GUIDED BIOPSY, 2018-2023 (USD MILLION)
• TABLE 66. AMERICAS BIOPSY DEVICES MARKET SIZE, BY IMAGE GUIDED BIOPSY, 2024-2030 (USD MILLION)
• TABLE 67. AMERICAS BIOPSY DEVICES MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
• TABLE 68. AMERICAS BIOPSY DEVICES MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
• TABLE 69. AMERICAS BIOPSY DEVICES MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
• TABLE 70. AMERICAS BIOPSY DEVICES MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
• TABLE 71. AMERICAS BIOPSY DEVICES MARKET SIZE, BY COUNTRY, 2018-2023 (USD MILLION)
• TABLE 72. AMERICAS BIOPSY DEVICES MARKET SIZE, BY COUNTRY, 2024-2030 (USD MILLION)
• TABLE 73. ARGENTINA BIOPSY DEVICES MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
• TABLE 74. ARGENTINA BIOPSY DEVICES MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
• TABLE 75. ARGENTINA BIOPSY DEVICES MARKET SIZE, BY NEEDLE-BASED BIOPSY INSTRUMENTS, 2018-2023 (USD MILLION)
• TABLE 76. ARGENTINA BIOPSY DEVICES MARKET SIZE, BY NEEDLE-BASED BIOPSY INSTRUMENTS, 2024-2030 (USD MILLION)
• TABLE 77. ARGENTINA BIOPSY DEVICES MARKET SIZE, BY TECHNIQUE, 2018-2023 (USD MILLION)
• TABLE 78. ARGENTINA BIOPSY DEVICES MARKET SIZE, BY TECHNIQUE, 2024-2030 (USD MILLION)
• TABLE 79. ARGENTINA BIOPSY DEVICES MARKET SIZE, BY IMAGE GUIDED BIOPSY, 2018-2023 (USD MILLION)
• TABLE 80. ARGENTINA BIOPSY DEVICES MARKET SIZE, BY IMAGE GUIDED BIOPSY, 2024-2030 (USD MILLION)
• TABLE 81. ARGENTINA BIOPSY DEVICES MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
• TABLE 82. ARGENTINA BIOPSY DEVICES MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
• TABLE 83. ARGENTINA BIOPSY DEVICES MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
• TABLE 84. ARGENTINA BIOPSY DEVICES MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
• TABLE 85. BRAZIL BIOPSY DEVICES MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
• TABLE 86. BRAZIL BIOPSY DEVICES MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
• TABLE 87. BRAZIL BIOPSY DEVICES MARKET SIZE, BY NEEDLE-BASED BIOPSY INSTRUMENTS, 2018-2023 (USD MILLION)
• TABLE 88. BRAZIL BIOPSY DEVICES MARKET SIZE, BY NEEDLE-BASED BIOPSY INSTRUMENTS, 2024-2030 (USD MILLION)
• TABLE 89. BRAZIL BIOPSY DEVICES MARKET SIZE, BY TECHNIQUE, 2018-2023 (USD MILLION)
• TABLE 90. BRAZIL BIOPSY DEVICES MARKET SIZE, BY TECHNIQUE, 2024-2030 (USD MILLION)
• TABLE 91. BRAZIL BIOPSY DEVICES MARKET SIZE, BY IMAGE GUIDED BIOPSY, 2018-2023 (USD MILLION)
• TABLE 92. BRAZIL BIOPSY DEVICES MARKET SIZE, BY IMAGE GUIDED BIOPSY, 2024-2030 (USD MILLION)
• TABLE 93. BRAZIL BIOPSY DEVICES MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
• TABLE 94. BRAZIL BIOPSY DEVICES MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
• TABLE 95. BRAZIL BIOPSY DEVICES MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
• TABLE 96. BRAZIL BIOPSY DEVICES MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
• TABLE 97. CANADA BIOPSY DEVICES MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
• TABLE 98. CANADA BIOPSY DEVICES MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
• TABLE 99. CANADA BIOPSY DEVICES MARKET SIZE, BY NEEDLE-BASED BIOPSY INSTRUMENTS, 2018-2023 (USD MILLION)
• TABLE 100. CANADA BIOPSY DEVICES MARKET SIZE, BY NEEDLE-BASED BIOPSY INSTRUMENTS, 2024-2030 (USD MILLION)
• TABLE 101. CANADA BIOPSY DEVICES MARKET SIZE, BY TECHNIQUE, 2018-2023 (USD MILLION)
• TABLE 102. CANADA BIOPSY DEVICES MARKET SIZE, BY TECHNIQUE, 2024-2030 (USD MILLION)
• TABLE 103. CANADA BIOPSY DEVICES MARKET SIZE, BY IMAGE GUIDED BIOPSY, 2018-2023 (USD MILLION)
• TABLE 104. CANADA BIOPSY DEVICES MARKET SIZE, BY IMAGE GUIDED BIOPSY, 2024-2030 (USD MILLION)
• TABLE 105. CANADA BIOPSY DEVICES MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
• TABLE 106. CANADA BIOPSY DEVICES MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
• TABLE 107. CANADA BIOPSY DEVICES MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
• TABLE 108. CANADA BIOPSY DEVICES MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
• TABLE 109. MEXICO BIOPSY DEVICES MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
• TABLE 110. MEXICO BIOPSY DEVICES MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
• TABLE 111. MEXICO BIOPSY DEVICES MARKET SIZE, BY NEEDLE-BASED BIOPSY INSTRUMENTS, 2018-2023 (USD MILLION)
• TABLE 112. MEXICO BIOPSY DEVICES MARKET SIZE, BY NEEDLE-BASED BIOPSY INSTRUMENTS, 2024-2030 (USD MILLION)
• TABLE 113. MEXICO BIOPSY DEVICES MARKET SIZE, BY TECHNIQUE, 2018-2023 (USD MILLION)
• TABLE 114. MEXICO BIOPSY DEVICES MARKET SIZE, BY TECHNIQUE, 2024-2030 (USD MILLION)
• TABLE 115. MEXICO BIOPSY DEVICES MARKET SIZE, BY IMAGE GUIDED BIOPSY, 2018-2023 (USD MILLION)
• TABLE 116. MEXICO BIOPSY DEVICES MARKET SIZE, BY IMAGE GUIDED BIOPSY, 2024-2030 (USD MILLION)
• TABLE 117. MEXICO BIOPSY DEVICES MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
• TABLE 118. MEXICO BIOPSY DEVICES MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
• TABLE 119. MEXICO BIOPSY DEVICES MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
• TABLE 120. MEXICO BIOPSY DEVICES MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
• TABLE 121. UNITED STATES BIOPSY DEVICES MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
• TABLE 122. UNITED STATES BIOPSY DEVICES MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
• TABLE 123. UNITED STATES BIOPSY DEVICES MARKET SIZE, BY NEEDLE-BASED BIOPSY INSTRUMENTS, 2018-2023 (USD MILLION)
• TABLE 124. UNITED STATES BIOPSY DEVICES MARKET SIZE, BY NEEDLE-BASED BIOPSY INSTRUMENTS, 2024-2030 (USD MILLION)
• TABLE 125. UNITED STATES BIOPSY DEVICES MARKET SIZE, BY TECHNIQUE, 2018-2023 (USD MILLION)
• TABLE 126. UNITED STATES BIOPSY DEVICES MARKET SIZE, BY TECHNIQUE, 2024-2030 (USD MILLION)
• TABLE 127. UNITED STATES BIOPSY DEVICES MARKET SIZE, BY IMAGE GUIDED BIOPSY, 2018-2023 (USD MILLION)
• TABLE 128. UNITED STATES BIOPSY DEVICES MARKET SIZE, BY IMAGE GUIDED BIOPSY, 2024-2030 (USD MILLION)
• TABLE 129. UNITED STATES BIOPSY DEVICES MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
• TABLE 130. UNITED STATES BIOPSY DEVICES MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
• TABLE 131. UNITED STATES BIOPSY DEVICES MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
• TABLE 132. UNITED STATES BIOPSY DEVICES MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
• TABLE 133. UNITED STATES BIOPSY DEVICES MARKET SIZE, BY STATE, 2018-2023 (USD MILLION)
• TABLE 134. UNITED STATES BIOPSY DEVICES MARKET SIZE, BY STATE, 2024-2030 (USD MILLION)
• TABLE 135. ASIA-PACIFIC BIOPSY DEVICES MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
• TABLE 136. ASIA-PACIFIC BIOPSY DEVICES MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
• TABLE 137. ASIA-PACIFIC BIOPSY DEVICES MARKET SIZE, BY NEEDLE-BASED BIOPSY INSTRUMENTS, 2018-2023 (USD MILLION)
• TABLE 138. ASIA-PACIFIC BIOPSY DEVICES MARKET SIZE, BY NEEDLE-BASED BIOPSY INSTRUMENTS, 2024-2030 (USD MILLION)
• TABLE 139. ASIA-PACIFIC BIOPSY DEVICES MARKET SIZE, BY TECHNIQUE, 2018-2023 (USD MILLION)
• TABLE 140. ASIA-PACIFIC BIOPSY DEVICES MARKET SIZE, BY TECHNIQUE, 2024-2030 (USD MILLION)
• TABLE 141. ASIA-PACIFIC BIOPSY DEVICES MARKET SIZE, BY IMAGE GUIDED BIOPSY, 2018-2023 (USD MILLION)
• TABLE 142. ASIA-PACIFIC BIOPSY DEVICES MARKET SIZE, BY IMAGE GUIDED BIOPSY, 2024-2030 (USD MILLION)
• TABLE 143. ASIA-PACIFIC BIOPSY DEVICES MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
• TABLE 144. ASIA-PACIFIC BIOPSY DEVICES MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
• TABLE 145. ASIA-PACIFIC BIOPSY DEVICES MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
• TABLE 146. ASIA-PACIFIC BIOPSY DEVICES MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
• TABLE 147. ASIA-PACIFIC BIOPSY DEVICES MARKET SIZE, BY COUNTRY, 2018-2023 (USD MILLION)
• TABLE 148. ASIA-PACIFIC BIOPSY DEVICES MARKET SIZE, BY COUNTRY, 2024-2030 (USD MILLION)
• TABLE 149. AUSTRALIA BIOPSY DEVICES MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
• TABLE 150. AUSTRALIA BIOPSY DEVICES MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
• TABLE 151. AUSTRALIA BIOPSY DEVICES MARKET SIZE, BY NEEDLE-BASED BIOPSY INSTRUMENTS, 2018-2023 (USD MILLION)
• TABLE 152. AUSTRALIA BIOPSY DEVICES MARKET SIZE, BY NEEDLE-BASED BIOPSY INSTRUMENTS, 2024-2030 (USD MILLION)
• TABLE 153. AUSTRALIA BIOPSY DEVICES MARKET SIZE, BY TECHNIQUE, 2018-2023 (USD MILLION)
• TABLE 154. AUSTRALIA BIOPSY DEVICES MARKET SIZE, BY TECHNIQUE, 2024-2030 (USD MILLION)
• TABLE 155. AUSTRALIA BIOPSY DEVICES MARKET SIZE, BY IMAGE GUIDED BIOPSY, 2018-2023 (USD MILLION)
• TABLE 156. AUSTRALIA BIOPSY DEVICES MARKET SIZE, BY IMAGE GUIDED BIOPSY, 2024-2030 (USD MILLION)
• TABLE 157. AUSTRALIA BIOPSY DEVICES MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
• TABLE 158. AUSTRALIA BIOPSY DEVICES MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
• TABLE 159. AUSTRALIA BIOPSY DEVICES MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
• TABLE 160. AUSTRALIA BIOPSY DEVICES MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
• TABLE 161. CHINA BIOPSY DEVICES MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
• TABLE 162. CHINA BIOPSY DEVICES MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
• TABLE 163. CHINA BIOPSY DEVICES MARKET SIZE, BY NEEDLE-BASED BIOPSY INSTRUMENTS, 2018-2023 (USD MILLION)
• TABLE 164. CHINA BIOPSY DEVICES MARKET SIZE, BY NEEDLE-BASED BIOPSY INSTRUMENTS, 2024-2030 (USD MILLION)
• TABLE 165. CHINA BIOPSY DEVICES MARKET SIZE, BY TECHNIQUE, 2018-2023 (USD MILLION)
• TABLE 166. CHINA BIOPSY DEVICES MARKET SIZE, BY TECHNIQUE, 2024-2030 (USD MILLION)
• TABLE 167. CHINA BIOPSY DEVICES MARKET SIZE, BY IMAGE GUIDED BIOPSY, 2018-2023 (USD MILLION)
• TABLE 168. CHINA BIOPSY DEVICES MARKET SIZE, BY IMAGE GUIDED BIOPSY, 2024-2030 (USD MILLION)
• TABLE 169. CHINA BIOPSY DEVICES MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
• TABLE 170. CHINA BIOPSY DEVICES MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
• TABLE 171. CHINA BIOPSY DEVICES MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
• TABLE 172. CHINA BIOPSY DEVICES MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
• TABLE 173. INDIA BIOPSY DEVICES MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
• TABLE 174. INDIA BIOPSY DEVICES MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
• TABLE 175. INDIA BIOPSY DEVICES MARKET SIZE, BY NEEDLE-BASED BIOPSY INSTRUMENTS, 2018-2023 (USD MILLION)
• TABLE 176. INDIA BIOPSY DEVICES MARKET SIZE, BY NEEDLE-BASED BIOPSY INSTRUMENTS, 2024-2030 (USD MILLION)
• TABLE 177. INDIA BIOPSY DEVICES MARKET SIZE, BY TECHNIQUE, 2018-2023 (USD MILLION)
• TABLE 178. INDIA BIOPSY DEVICES MARKET SIZE, BY TECHNIQUE, 2024-2030 (USD MILLION)
• TABLE 179. INDIA BIOPSY DEVICES MARKET SIZE, BY IMAGE GUIDED BIOPSY, 2018-2023 (USD MILLION)
• TABLE 180. INDIA BIOPSY DEVICES MARKET SIZE, BY IMAGE GUIDED BIOPSY, 2024-2030 (USD MILLION)
• TABLE 181. INDIA BIOPSY DEVICES MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
• TABLE 182. INDIA BIOPSY DEVICES MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
• TABLE 183. INDIA BIOPSY DEVICES MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
• TABLE 184. INDIA BIOPSY DEVICES MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
• TABLE 185. INDONESIA BIOPSY DEVICES MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
• TABLE 186. INDONESIA BIOPSY DEVICES MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
• TABLE 187. INDONESIA BIOPSY DEVICES MARKET SIZE, BY NEEDLE-BASED BIOPSY INSTRUMENTS, 2018-2023 (USD MILLION)
• TABLE 188. INDONESIA BIOPSY DEVICES MARKET SIZE, BY NEEDLE-BASED BIOPSY INSTRUMENTS, 2024-2030 (USD MILLION)
• TABLE 189. INDONESIA BIOPSY DEVICES MARKET SIZE, BY TECHNIQUE, 2018-2023 (USD MILLION)
• TABLE 190. INDONESIA BIOPSY DEVICES MARKET SIZE, BY TECHNIQUE, 2024-2030 (USD MILLION)
• TABLE 191. INDONESIA BIOPSY DEVICES MARKET SIZE, BY IMAGE GUIDED BIOPSY, 2018-2023 (USD MILLION)
• TABLE 192. INDONESIA BIOPSY DEVICES MARKET SIZE, BY IMAGE GUIDED BIOPSY, 2024-2030 (USD MILLION)
• TABLE 193. INDONESIA BIOPSY DEVICES MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
• TABLE 194. INDONESIA BIOPSY DEVICES MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
• TABLE 195. INDONESIA BIOPSY DEVICES MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
• TABLE 196. INDONESIA BIOPSY DEVICES MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
• TABLE 197. JAPAN BIOPSY DEVICES MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
• TABLE 198. JAPAN BIOPSY DEVICES MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
• TABLE 199. JAPAN BIOPSY DEVICES MARKET SIZE, BY NEEDLE-BASED BIOPSY INSTRUMENTS, 2018-2023 (USD MILLION)
• TABLE 200. JAPAN BIOPSY DEVICES MARKET SIZE, BY NEEDLE-BASED BIOPSY INSTRUMENTS, 2024-2030 (USD MILLION)
• TABLE 201. JAPAN BIOPSY DEVICES MARKET SIZE, BY TECHNIQUE, 2018-2023 (USD MILLION)
• TABLE 202. JAPAN BIOPSY DEVICES MARKET SIZE, BY TECHNIQUE, 2024-2030 (USD MILLION)
• TABLE 203. JAPAN BIOPSY DEVICES MARKET SIZE, BY IMAGE GUIDED BIOPSY, 2018-2023 (USD MILLION)
• TABLE 204. JAPAN BIOPSY DEVICES MARKET SIZE, BY IMAGE GUIDED BIOPSY, 2024-2030 (USD MILLION)
• TABLE 205. JAPAN BIOPSY DEVICES MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
• TABLE 206. JAPAN BIOPSY DEVICES MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
• TABLE 207. JAPAN BIOPSY DEVICES MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
• TABLE 208. JAPAN BIOPSY DEVICES MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
• TABLE 209. MALAYSIA BIOPSY DEVICES MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
• TABLE 210. MALAYSIA BIOPSY DEVICES MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
• TABLE 211. MALAYSIA BIOPSY DEVICES MARKET SIZE, BY NEEDLE-BASED BIOPSY INSTRUMENTS, 2018-2023 (USD MILLION)
• TABLE 212. MALAYSIA BIOPSY DEVICES MARKET SIZE, BY NEEDLE-BASED BIOPSY INSTRUMENTS, 2024-2030 (USD MILLION)
• TABLE 213. MALAYSIA BIOPSY DEVICES MARKET SIZE, BY TECHNIQUE, 2018-2023 (USD MILLION)
• TABLE 214. MALAYSIA BIOPSY DEVICES MARKET SIZE, BY TECHNIQUE, 2024-2030 (USD MILLION)
• TABLE 215. MALAYSIA BIOPSY DEVICES MARKET SIZE, BY IMAGE GUIDED BIOPSY, 2018-2023 (USD MILLION)
• TABLE 216. MALAYSIA BIOPSY DEVICES MARKET SIZE, BY IMAGE GUIDED BIOPSY, 2024-2030 (USD MILLION)
• TABLE 217. MALAYSIA BIOPSY DEVICES MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
• TABLE 218. MALAYSIA BIOPSY DEVICES MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
• TABLE 219. MALAYSIA BIOPSY DEVICES MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
• TABLE 220. MALAYSIA BIOPSY DEVICES MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
• TABLE 221. PHILIPPINES BIOPSY DEVICES MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
• TABLE 222. PHILIPPINES BIOPSY DEVICES MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
• TABLE 223. PHILIPPINES BIOPSY DEVICES MARKET SIZE, BY NEEDLE-BASED BIOPSY INSTRUMENTS, 2018-2023 (USD MILLION)
• TABLE 224. PHILIPPINES BIOPSY DEVICES MARKET SIZE, BY NEEDLE-BASED BIOPSY INSTRUMENTS, 2024-2030 (USD MILLION)
• TABLE 225. PHILIPPINES BIOPSY DEVICES MARKET SIZE, BY TECHNIQUE, 2018-2023 (USD MILLION)
• TABLE 226. PHILIPPINES BIOPSY DEVICES MARKET SIZE, BY TECHNIQUE, 2024-2030 (USD MILLION)
• TABLE 227. PHILIPPINES BIOPSY DEVICES MARKET SIZE, BY IMAGE GUIDED BIOPSY, 2018-2023 (USD MILLION)
• TABLE 228. PHILIPPINES BIOPSY DEVICES MARKET SIZE, BY IMAGE GUIDED BIOPSY, 2024-2030 (USD MILLION)
• TABLE 229. PHILIPPINES BIOPSY DEVICES MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
• TABLE 230. PHILIPPINES BIOPSY DEVICES MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
• TABLE 231. PHILIPPINES BIOPSY DEVICES MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
• TABLE 232. PHILIPPINES BIOPSY DEVICES MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
• TABLE 233. SINGAPORE BIOPSY DEVICES MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
• TABLE 234. SINGAPORE BIOPSY DEVICES MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
• TABLE 235. SINGAPORE BIOPSY DEVICES MARKET SIZE, BY NEEDLE-BASED BIOPSY INSTRUMENTS, 2018-2023 (USD MILLION)
• TABLE 236. SINGAPORE BIOPSY DEVICES MARKET SIZE, BY NEEDLE-BASED BIOPSY INSTRUMENTS, 2024-2030 (USD MILLION)
• TABLE 237. SINGAPORE BIOPSY DEVICES MARKET SIZE, BY TECHNIQUE, 2018-2023 (USD MILLION)
• TABLE 238. SINGAPORE BIOPSY DEVICES MARKET SIZE, BY TECHNIQUE, 2024-2030 (USD MILLION)
• TABLE 239. SINGAPORE BIOPSY DEVICES MARKET SIZE, BY IMAGE GUIDED BIOPSY, 2018-2023 (USD MILLION)
• TABLE 240. SINGAPORE BIOPSY DEVICES MARKET SIZE, BY IMAGE GUIDED BIOPSY, 2024-2030 (USD MILLION)
• TABLE 241. SINGAPORE BIOPSY DEVICES MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
• TABLE 242. SINGAPORE BIOPSY DEVICES MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
• TABLE 243. SINGAPORE BIOPSY DEVICES MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
• TABLE 244. SINGAPORE BIOPSY DEVICES MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
• TABLE 245. SOUTH KOREA BIOPSY DEVICES MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
• TABLE 246. SOUTH KOREA BIOPSY DEVICES MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
• TABLE 247. SOUTH KOREA BIOPSY DEVICES MARKET SIZE, BY NEEDLE-BASED BIOPSY INSTRUMENTS, 2018-2023 (USD MILLION)
• TABLE 248. SOUTH KOREA BIOPSY DEVICES MARKET SIZE, BY NEEDLE-BASED BIOPSY INSTRUMENTS, 2024-2030 (USD MILLION)
• TABLE 249. SOUTH KOREA BIOPSY DEVICES MARKET SIZE, BY TECHNIQUE, 2018-2023 (USD MILLION)
• TABLE 250. SOUTH KOREA BIOPSY DEVICES MARKET SIZE, BY TECHNIQUE, 2024-2030 (USD MILLION)
• TABLE 251. SOUTH KOREA BIOPSY DEVICES MARKET SIZE, BY IMAGE GUIDED BIOPSY, 2018-2023 (USD MILLION)
• TABLE 252. SOUTH KOREA BIOPSY DEVICES MARKET SIZE, BY IMAGE GUIDED BIOPSY, 2024-2030 (USD MILLION)
• TABLE 253. SOUTH KOREA BIOPSY DEVICES MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
• TABLE 254. SOUTH KOREA BIOPSY DEVICES MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
• TABLE 255. SOUTH KOREA BIOPSY DEVICES MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
• TABLE 256. SOUTH KOREA BIOPSY DEVICES MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
• TABLE 257. TAIWAN BIOPSY DEVICES MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
• TABLE 258. TAIWAN BIOPSY DEVICES MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
• TABLE 259. TAIWAN BIOPSY DEVICES MARKET SIZE, BY NEEDLE-BASED BIOPSY INSTRUMENTS, 2018-2023 (USD MILLION)
• TABLE 260. TAIWAN BIOPSY DEVICES MARKET SIZE, BY NEEDLE-BASED BIOPSY INSTRUMENTS, 2024-2030 (USD MILLION)
• TABLE 261. TAIWAN BIOPSY DEVICES MARKET SIZE, BY TECHNIQUE, 2018-2023 (USD MILLION)
• TABLE 262. TAIWAN BIOPSY DEVICES MARKET SIZE, BY TECHNIQUE, 2024-2030 (USD MILLION)
• TABLE 263. TAIWAN BIOPSY DEVICES MARKET SIZE, BY IMAGE GUIDED BIOPSY, 2018-2023 (USD MILLION)
• TABLE 264. TAIWAN BIOPSY DEVICES MARKET SIZE, BY IMAGE GUIDED BIOPSY, 2024-2030 (USD MILLION)
• TABLE 265. TAIWAN BIOPSY DEVICES MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
• TABLE 266. TAIWAN BIOPSY DEVICES MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
• TABLE 267. TAIWAN BIOPSY DEVICES MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
• TABLE 268. TAIWAN BIOPSY DEVICES MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
• TABLE 269. THAILAND BIOPSY DEVICES MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
• TABLE 270. THAILAND BIOPSY DEVICES MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
• TABLE 271. THAILAND BIOPSY DEVICES MARKET SIZE, BY NEEDLE-BASED BIOPSY INSTRUMENTS, 2018-2023 (USD MILLION)
• TABLE 272. THAILAND BIOPSY DEVICES MARKET SIZE, BY NEEDLE-BASED BIOPSY INSTRUMENTS, 2024-2030 (USD MILLION)
• TABLE 273. THAILAND BIOPSY DEVICES MARKET SIZE, BY TECHNIQUE, 2018-2023 (USD MILLION)
• TABLE 274. THAILAND BIOPSY DEVICES MARKET SIZE, BY TECHNIQUE, 2024-2030 (USD MILLION)
• TABLE 275. THAILAND BIOPSY DEVICES MARKET SIZE, BY IMAGE GUIDED BIOPSY, 2018-2023 (USD MILLION)
• TABLE 276. THAILAND BIOPSY DEVICES MARKET SIZE, BY IMAGE GUIDED BIOPSY, 2024-2030 (USD MILLION)
• TABLE 277. THAILAND BIOPSY DEVICES MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
• TABLE 278. THAILAND BIOPSY DEVICES MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
• TABLE 279. THAILAND BIOPSY DEVICES MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
• TABLE 280. THAILAND BIOPSY DEVICES MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
• TABLE 281. VIETNAM BIOPSY DEVICES MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
• TABLE 282. VIETNAM BIOPSY DEVICES MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
• TABLE 283. VIETNAM BIOPSY DEVICES MARKET SIZE, BY NEEDLE-BASED BIOPSY INSTRUMENTS, 2018-2023 (USD MILLION)
• TABLE 284. VIETNAM BIOPSY DEVICES MARKET SIZE, BY NEEDLE-BASED BIOPSY INSTRUMENTS, 2024-2030 (USD MILLION)
• TABLE 285. VIETNAM BIOPSY DEVICES MARKET SIZE, BY TECHNIQUE, 2018-2023 (USD MILLION)
• TABLE 286. VIETNAM BIOPSY DEVICES MARKET SIZE, BY TECHNIQUE, 2024-2030 (USD MILLION)
• TABLE 287. VIETNAM BIOPSY DEVICES MARKET SIZE, BY IMAGE GUIDED BIOPSY, 2018-2023 (USD MILLION)
• TABLE 288. VIETNAM BIOPSY DEVICES MARKET SIZE, BY IMAGE GUIDED BIOPSY, 2024-2030 (USD MILLION)
• TABLE 289. VIETNAM BIOPSY DEVICES MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
• TABLE 290. VIETNAM BIOPSY DEVICES MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
• TABLE 291. VIETNAM BIOPSY DEVICES MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
• TABLE 292. VIETNAM BIOPSY DEVICES MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
• TABLE 293. EUROPE, MIDDLE EAST & AFRICA BIOPSY DEVICES MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
• TABLE 294. EUROPE, MIDDLE EAST & AFRICA BIOPSY DEVICES MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
• TABLE 295. EUROPE, MIDDLE EAST & AFRICA BIOPSY DEVICES MARKET SIZE, BY NEEDLE-BASED BIOPSY INSTRUMENTS, 2018-2023 (USD MILLION)
• TABLE 296. EUROPE, MIDDLE EAST & AFRICA BIOPSY DEVICES MARKET SIZE, BY NEEDLE-BASED BIOPSY INSTRUMENTS, 2024-2030 (USD MILLION)
• TABLE 297. EUROPE, MIDDLE EAST & AFRICA BIOPSY DEVICES MARKET SIZE, BY TECHNIQUE, 2018-2023 (USD MILLION)
• TABLE 298. EUROPE, MIDDLE EAST & AFRICA BIOPSY DEVICES MARKET SIZE, BY TECHNIQUE, 2024-2030 (USD MILLION)
• TABLE 299. EUROPE, MIDDLE EAST & AFRICA BIOPSY DEVICES MARKET SIZE, BY IMAGE GUIDED BIOPSY, 2018-2023 (USD MILLION)
• TABLE 300. EUROPE, MIDDLE EAST & AFRICA BIOPSY DEVICES MARKET SIZE, BY IMAGE GUIDED BIOPSY, 2024-2030 (USD MILLION)
• TABLE 301. EUROPE, MIDDLE EAST & AFRICA BIOPSY DEVICES MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
• TABLE 302. EUROPE, MIDDLE EAST & AFRICA BIOPSY DEVICES MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
• TABLE 303. EUROPE, MIDDLE EAST & AFRICA BIOPSY DEVICES MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
• TABLE 304. EUROPE, MIDDLE EAST & AFRICA BIOPSY DEVICES MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
• TABLE 305. EUROPE, MIDDLE EAST & AFRICA BIOPSY DEVICES MARKET SIZE, BY COUNTRY, 2018-2023 (USD MILLION)
• TABLE 306. EUROPE, MIDDLE EAST & AFRICA BIOPSY DEVICES MARKET SIZE, BY COUNTRY, 2024-2030 (USD MILLION)
• TABLE 307. DENMARK BIOPSY DEVICES MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
• TABLE 308. DENMARK BIOPSY DEVICES MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
• TABLE 309. DENMARK BIOPSY DEVICES MARKET SIZE, BY NEEDLE-BASED BIOPSY INSTRUMENTS, 2018-2023 (USD MILLION)
• TABLE 310. DENMARK BIOPSY DEVICES MARKET SIZE, BY NEEDLE-BASED BIOPSY INSTRUMENTS, 2024-2030 (USD MILLION)
• TABLE 311. DENMARK BIOPSY DEVICES MARKET SIZE, BY TECHNIQUE, 2018-2023 (USD MILLION)
• TABLE 312. DENMARK BIOPSY DEVICES MARKET SIZE, BY TECHNIQUE, 2024-2030 (USD MILLION)
• TABLE 313. DENMARK BIOPSY DEVICES MARKET SIZE, BY IMAGE GUIDED BIOPSY, 2018-2023 (USD MILLION)
• TABLE 314. DENMARK BIOPSY DEVICES MARKET SIZE, BY IMAGE GUIDED BIOPSY, 2024-2030 (USD MILLION)
• TABLE 315. DENMARK BIOPSY DEVICES MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
• TABLE 316. DENMARK BIOPSY DEVICES MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
• TABLE 317. DENMARK BIOPSY DEVICES MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
• TABLE 318. DENMARK BIOPSY DEVICES MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
• TABLE 319. EGYPT BIOPSY DEVICES MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
• TABLE 320. EGYPT BIOPSY DEVICES MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
• TABLE 321. EGYPT BIOPSY DEVICES MARKET SIZE, BY NEEDLE-BASED BIOPSY INSTRUMENTS, 2018-2023 (USD MILLION)
• TABLE 322. EGYPT BIOPSY DEVICES MARKET SIZE, BY NEEDLE-BASED BIOPSY INSTRUMENTS, 2024-2030 (USD MILLION)
• TABLE 323. EGYPT BIOPSY DEVICES MARKET SIZE, BY TECHNIQUE, 2018-2023 (USD MILLION)
• TABLE 324. EGYPT BIOPSY DEVICES MARKET SIZE, BY TECHNIQUE, 2024-2030 (USD MILLION)
• TABLE 325. EGYPT BIOPSY DEVICES MARKET SIZE, BY IMAGE GUIDED BIOPSY, 2018-2023 (USD MILLION)
• TABLE 326. EGYPT BIOPSY DEVICES MARKET SIZE, BY IMAGE GUIDED BIOPSY, 2024-2030 (USD MILLION)
• TABLE 327. EGYPT BIOPSY DEVICES MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
• TABLE 328. EGYPT BIOPSY DEVICES MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
• TABLE 329. EGYPT BIOPSY DEVICES MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
• TABLE 330. EGYPT BIOPSY DEVICES MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
• TABLE 331. FINLAND BIOPSY DEVICES MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
• TABLE 332. FINLAND BIOPSY DEVICES MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
• TABLE 333. FINLAND BIOPSY DEVICES MARKET SIZE, BY NEEDLE-BASED BIOPSY INSTRUMENTS, 2018-2023 (USD MILLION)
• TABLE 334. FINLAND BIOPSY DEVICES MARKET SIZE, BY NEEDLE-BASED BIOPSY INSTRUMENTS, 2024-2030 (USD MILLION)
• TABLE 335. FINLAND BIOPSY DEVICES MARKET SIZE, BY TECHNIQUE, 2018-2023 (USD MILLION)
• TABLE 336. FINLAND BIOPSY DEVICES MARKET SIZE, BY TECHNIQUE, 2024-2030 (USD MILLION)
• TABLE 337. FINLAND BIOPSY DEVICES MARKET SIZE, BY IMAGE GUIDED BIOPSY, 2018-2023 (USD MILLION)
• TABLE 338. FINLAND BIOPSY DEVICES MARKET SIZE, BY IMAGE GUIDED BIOPSY, 2024-2030 (USD MILLION)
• TABLE 339. FINLAND BIOPSY DEVICES MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
• TABLE 340. FINLAND BIOPSY DEVICES MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
• TABLE 341. FINLAND BIOPSY DEVICES MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
• TABLE 342. FINLAND BIOPSY DEVICES MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
• TABLE 343. FRANCE BIOPSY DEVICES MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
• TABLE 344. FRANCE BIOPSY DEVICES MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
• TABLE 345. FRANCE BIOPSY DEVICES MARKET SIZE, BY NEEDLE-BASED BIOPSY INSTRUMENTS, 2018-2023 (USD MILLION)
• TABLE 346. FRANCE BIOPSY DEVICES MARKET SIZE, BY NEEDLE-BASED BIOPSY INSTRUMENTS, 2024-2030 (USD MILLION)
• TABLE 347. FRANCE BIOPSY DEVICES MARKET SIZE, BY TECHNIQUE, 2018-2023 (USD MILLION)
• TABLE 348. FRANCE BIOPSY DEVICES MARKET SIZE, BY TECHNIQUE, 2024-2030 (USD MILLION)
• TABLE 349. FRANCE BIOPSY DEVICES MARKET SIZE, BY IMAGE GUIDED BIOPSY, 2018-2023 (USD MILLION)
• TABLE 350. FRANCE BIOPSY DEVICES MARKET SIZE, BY IMAGE GUIDED BIOPSY, 2024-2030 (USD MILLION)
• TABLE 351. FRANCE BIOPSY DEVICES MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
• TABLE 352. FRANCE BIOPSY DEVICES MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
• TABLE 353. FRANCE BIOPSY DEVICES MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
• TABLE 354. FRANCE BIOPSY DEVICES MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
• TABLE 355. GERM

[183 Pages Report] The Biopsy Devices Market size was estimated at USD 9.47 billion in 2023 and expected to reach USD 10.46 billion in 2024, at a CAGR 10.82% to reach USD 19.46 billion by 2030.

The biopsy devices are used explicitly in diagnostic procedures that involve the extraction of sample cells and tissues for examination aimed at identifying the existence and extent of a disease. These devices range from needle biopsy devices, biopsy guidance systems to biopsy forceps. Biopsy devices have a crucial role in several medical applications pertaining to disease detection and monitoring, including breast biopsy, gastrointestinal biopsy, prostate biopsy, liver biopsy, and lung biopsy. An increasing prevalence of cancer worldwide and a growing preference for minimally invasive surgeries are pivotal factors driving the market growth. In contrast, high equipment costs, risks associated with biopsy procedures, and the stringent regulatory hurdles by health authorities hinder the market growth. However, several vendors are focusing on R&D to overcome these issues. Furthermore, advancements in the manufacturing process of biopsy devices, extending the usage of biopsy devices in research and tissue banking, improved healthcare infrastructures, and investments in emerging economies contribute to market expansion.

Product: Growing preference for needle-based biopsy instruments as it provide minimal risk of complications

Biopsy forceps are sophisticated, hand-held devices used during minimally invasive procedures, designed with a two-leaf structure; they are adept at extracting tissue samples from targeted areas with sheer precision and minimal patient discomfort. Localization wires act as a guide in identifying the correct area for biopsy, particularly in breast biopsy procedures. They are used preoperatively to seperate non-palpable lesions detected during mammography or ultrasound, ensuring precision and aiding radiologists in obtaining tissue samples. Needle-based biopsy instruments are preferred for deep-seated lesions; common types include fine-needle aspiration and core-needle biopsies. These devices reduce procedural complications and are known for their efficiency in obtaining high-quality samples, helping in precise diagnoses. Needle-based biopsy instruments include aspiration needles, core biopsy devices, and vacuum-assisted biopsy devices. Aspiration needles play a crucial role in fine-needle aspiration biopsy procedures, often used to investigate lumps or masses. Core biopsy devices remove a small tissue section for pathological examination, usually used in breast, liver, or bone biopsies. Vacuum-assisted biopsy devices are remarkably efficient tools for minimally invasive biopsy procedures. Employing a vacuum mechanism, these devices allow for a continuous tissue sample to be acquired without reinserting the needle. Procedure trays are a compact, systematic solution encompassing all necessary biopsy tools for a specific procedure. They optimize the workflow, promote efficient resource use, and enhance the sterility of the procedure.

Technique: Significant role of MRI-guided biopsy in biopsy device for high diagnosis accuracy

Image-guided biopsy is a noteworthy innovation in the realm of biopsy devices, harnessing the precision of modern imaging technologies. This advanced technique enables doctors to extract samples from difficult-to-access areas, leading to a more accurate and less invasive procedure. Image-guided biopsy includes MRI-guided biopsy, stereotactic-guided biopsies, and ultrasound-guided biopsy. MRI-guided biopsy has become a preferred technique for diagnosing abnormalities located in difficult-to-reach areas or those of more intricate structures such as the brain and the breast. Stereotactic-guided biopsies are more applicable for relatively superficial abnormalities, including those in the breast and lesions close to the skin. This technique is a boon for patients to avoid the discomfort of invasive procedures while still ensuring a highly accurate diagnosis. Ultrasound-guided biopsy primarily leverages its advantage in real-time image provision, making it the go-to option for neck, chest, and abdomen biopsies. Furthermore, it is a cost-effective and faster way of performing biopsies and is preferred in situations where cost and time are primary considerations. In comparison, MRI-guided biopsy stands at the forefront of advanced cases, stereotactic biopsy rings are necessary for superficial cases, and ultrasound-guided offerings are proven beneficial in real-time requirements and cost-effective scenarios. Non-image guided biopsy includes techniques where palpation or anatomical landmarks are used to determine the biopsy site without the assistance of live-image guidance. The choice between image-guided and non-image-guided biopsies largely depends on the location and nature of the lesion, the patient's health status, and the resources available. Image-guided biopsy methods are leading in the context of precision and safety, particularly for non-palpable and deep-seated lesions. However, non-image-guided procedures remain a fast and cost-effective option for superficial masses.

Application: Growing need for breast and prostate biopsy devices due to increasing instances of cancer in both areas

The upsurge in breast cancer cases worldwide has subsequently triggered the need for breast biopsy devices. Devices such as vacuum-assisted biopsy (VAB) systems attain favor for their minimally invasive nature, confident diagnosis, and high-speed, painless process. Flexible sigmoidoscopes are preferred for colorectal biopsy due to their ability to detect abnormalities in the rectum and sigmoid colon. The rising incidence of lung conditions, including cancer, triggers the need for lung biopsy devices, where transthoracic needle biopsy (TTNB) devices are commonly used. Prostate biopsy procedures largely use transrectal ultrasound (TRUS) guided prostate biopsy devices, as per need-based preference. Biopsy devices for breast and prostate biopsies are undergoing significant technological advancement owing to rising cancer rates. Simultaneously, devices for lung and colorectal biopsies address a range of illnesses, cancer included. Biopsy devices remain paramount in medical diagnosis, reflecting continuous progress and ensuring patient health.

End User: Rising utilization of biopsy devices that promote lesser recovery time in the hospitals

Academic and research institutes pursue innovative solutions for improving the accuracy and efficiency of biopsy procedures, with a particular emphasis on non-invasive techniques. These institutions seek sophisticated and advanced biopsy devices that allow them to explore new frontiers of medical research. Diagnostic and imaging centers focus primarily on timely and accurate diagnosis. They require biopsy devices that facilitate rapid sample collection with minimal patient discomfort. Biopsy devices that allow for shorter recovery times, fewer complications, and lower costs are ideally preferred by primary healthcare providers and hospitals as they mainly focus on patient safety, comfort, and cost-effectiveness. The shared objective across these user groups is to enhance biopsy procedure accuracy and efficiency. The varied sector needs to drive market evolution, promising more subtle innovations and improved global health outcomes.

Regional Insights

The Americas region has witnessed a rising trend in the utilization of biopsy devices due to the increase in various cancer cases. According to the American Cancer Society, in 2023, there are estimated to be 1,958,310 new cancer cases. This directly contributes to the need for biopsy devices. State-of-the-art technology and medical advancements, alongside favorable reimbursement policies in this region, contribute to the market growth. Also, growing awareness about early detection of cancer, reinforced by strong healthcare marketing, paves the path for increased use of biopsy devices in the region. Furthermore, the EMEA region, characterized by rapidly aging populations and a high incidence of cancer, has a strong need for biopsy devices. The market inflow is also credited to the adoption of technologically advanced healthcare equipment and infrastructure. National healthcare systems in this region promote timely and accurate cancer diagnosis, enabling increased biopsy device utilization. The awareness campaigns by the World Health Organization (WHO) and the European Institute of Oncology stimulate the need for biopsy devices in the region. Moreover, the APAC region is experiencing a rapid increase in lifestyle-related diseases, including cancers. The aging population, environmental pollution, and unhealthy lifestyle habits are fueling the incidences of cancer, thereby increasing the need for biopsy devices. In addition, improving healthcare systems, increasing healthcare spending, and raising awareness about early cancer detection are other factors fostering the adoption of biopsy devices.

FPNV Positioning Matrix

The FPNV Positioning Matrix is pivotal in evaluating the Biopsy Devices Market. It offers a comprehensive assessment of vendors, examining key metrics related to Business Strategy and Product Satisfaction. This in-depth analysis empowers users to make well-informed decisions aligned with their requirements. Based on the evaluation, the vendors are then categorized into four distinct quadrants representing varying levels of success: Forefront (F), Pathfinder (P), Niche (N), or Vital (V).

Market Share Analysis

The Market Share Analysis is a comprehensive tool that provides an insightful and in-depth examination of the current state of vendors in the Biopsy Devices Market. By meticulously comparing and analyzing vendor contributions in terms of overall revenue, customer base, and other key metrics, we can offer companies a greater understanding of their performance and the challenges they face when competing for market share. Additionally, this analysis provides valuable insights into the competitive nature of the sector, including factors such as accumulation, fragmentation dominance, and amalgamation traits observed over the base year period studied. With this expanded level of detail, vendors can make more informed decisions and devise effective strategies to gain a competitive edge in the market.

Key Company Profiles

The report delves into recent significant developments in the Biopsy Devices Market, highlighting leading vendors and their innovative profiles. These include Advin Health Care, Argon Medical Devices, Inc., Axlab Limited, B. Braun SE, Becton, Dickinson and Company, Boston Scientific Corporation, Cardinal Health, Inc., CONMED Corporation, Cook Group Incorporated, Danaher Corporation, F. Hoffmann-La Roche Ltd., Ferrosan Medical Devices A/S, Fujifilm Holdings Corporation, Guardant Health, Inc., Hologic, Inc., Innovia Medical, INRAD, Inc., Integra LifeSciences Holdings Corporation, IZI Medical Products, LLC by Halma PLC, JEB Technologies Limited, Limaca-Medical, MediTech Devices Pvt Ltd., Medtronic PLC, Merit Medical Systems, Inc., Mermaid Medical, Olympus Corporation, PAJUNK GmbH Medizintechnologie, Remington Medical, Spectra Medical Devices, LLC, Stryker Corporation, Suretech Medical Inc., Trajan Scientific and Medical Pty Ltd., TransMed7, LLC, TSK Laboratory, UVision360, Volkmann MedizinTechnik GmbH, weLLgo Medical Products GmbH, and Zamar Care.

Market Segmentation & Coverage

This research report categorizes the Biopsy Devices Market to forecast the revenues and analyze trends in each of the following sub-markets:

• Product
  • Biopsy Forceps
  • Localization Wires
  • Needle-Based Biopsy Instruments
    • Aspiration Needles
    • Core Biopsy Devices
    • Vacuum-Assisted Biopsy Devices

• Procedure Trays

• Technique
  • Image Guided Biopsy
    • MRI-Guided Biopsy
    • Stereotactic-Guided Biopsy
    • Ultrasound-Guided Biopsy

• Non-Image Guided Biopsy

• Application
  • Bone Marrow Biopsy
  • Breast Biopsy
  • Kidney Biopsy
  • Lung Biopsy
  • Prostate Biopsy

• End User
  • Academic & Research Institutes
  • Diagnostic & Imaging Centers
  • Hospitals

• Region
  • Americas
    • Argentina
    • Brazil
    • Canada
    • Mexico
    • United States
      • California
      • Florida
      • Illinois
      • New York
      • Ohio
      • Pennsylvania
      • Texas
  • Asia-Pacific
    • Australia
    • China
    • India
    • Indonesia
    • Japan
    • Malaysia
    • Philippines
    • Singapore
    • South Korea
    • Taiwan
    • Thailand
    • Vietnam

• Europe, Middle East & Africa
  • Denmark
  • Egypt
  • Finland
  • France
  • Germany
  • Israel
  • Italy
  • Netherlands
  • Nigeria
  • Norway
  • Poland
  • Qatar
  • Russia
  • Saudi Arabia
  • South Africa
  • Spain
  • Sweden
  • Switzerland
  • Turkey
  • United Arab Emirates
  • United Kingdom

The report offers valuable insights on the following aspects:

1. Market Penetration: It presents comprehensive information on the market provided by key players.

2. Market Development: It delves deep into lucrative emerging markets and analyzes the penetration across mature market segments.

3. Market Diversification: It provides detailed information on new product launches, untapped geographic regions, recent developments, and investments.

4. Competitive Assessment & Intelligence: It conducts an exhaustive assessment of market shares, strategies, products, certifications, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players.

5. Product Development & Innovation: It offers intelligent insights on future technologies, R&D activities, and breakthrough product developments.

The report addresses key questions such as:

1. What is the market size and forecast of the Biopsy Devices Market?

2. Which products, segments, applications, and areas should one consider investing in over the forecast period in the Biopsy Devices Market?

3. What are the technology trends and regulatory frameworks in the Biopsy Devices Market?

4. What is the market share of the leading vendors in the Biopsy Devices Market?

5. Which modes and strategic moves are suitable for entering the Biopsy Devices Market?

Table of Contents

1. Preface

• 1.1. Objectives of the Study
• 1.2. Market Segmentation & Coverage
• 1.3. Years Considered for the Study
• 1.4. Currency & Pricing
• 1.5. Language
• 1.6. Stakeholders

2. Research Methodology

• 2.1. Define: Research Objective
• 2.2. Determine: Research Design
• 2.3. Prepare: Research Instrument
• 2.4. Collect: Data Source
• 2.5. Analyze: Data Interpretation
• 2.6. Formulate: Data Verification
• 2.7. Publish: Research Report
• 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

• 5.1. Market Dynamics
  • 5.1.1. Drivers
    • 5.1.1.1. Growing incidences of cancer and gastrointestinal diseases
    • 5.1.1.2. Rise in adoption of minimally-invasive techniques
    • 5.1.1.3. Increasing awareness of the importance of early detection and screening of diseases
  • 5.1.2. Restraints
    • 5.1.2.1. High cost associated with the production of biopsy devices
  • 5.1.3. Opportunities
    • 5.1.3.1. Continuous technological advancements in biopsy devices
    • 5.1.3.2. Growing inclination towards liquid biopsy devices
  • 5.1.4. Challenges
    • 5.1.4.1. Problems associated with stringent regulations by health authorities
• 5.2. Market Segmentation Analysis
  • 5.2.1. Product: Growing preference for needle-based biopsy instruments as it provide minimal risk of complications
  • 5.2.2. Technique: Significant role of MRI-guided biopsy in biopsy device for high diagnosis accuracy
  • 5.2.3. Application: Growing need for breast and prostate biopsy devices due to increasing instances of cancer in both areas
  • 5.2.4. End User: Rising utilization of biopsy devices that promote lesser recovery time in the hospitals
• 5.3. Market Trend Analysis
  • 5.3.1. Growing research activities in developing novel biopsy devices coupled with robust presence of major companies in the Americas region
  • 5.3.2. Increasing product approvals from regional regulatory bodies coupled with growing research and development activities to expand the application of biopsy devices in the APAC region
  • 5.3.3. Advanced healthcare facilities and cancer detection and prevention program in the EMEA region
• 5.4. Cumulative Impact of High Inflation
• 5.5. Porter's Five Forces Analysis
  • 5.5.1. Threat of New Entrants
  • 5.5.2. Threat of Substitutes
  • 5.5.3. Bargaining Power of Customers
  • 5.5.4. Bargaining Power of Suppliers
  • 5.5.5. Industry Rivalry
• 5.6. Value Chain & Critical Path Analysis
• 5.7. Regulatory Framework Analysis

6. Biopsy Devices Market, by Product

• 6.1. Introduction
• 6.2. Biopsy Forceps
• 6.3. Localization Wires
• 6.4. Needle-Based Biopsy Instruments
• 6.5. Procedure Trays

7. Biopsy Devices Market, by Technique

• 7.1. Introduction
• 7.2. Image Guided Biopsy
• 7.3. Non-Image Guided Biopsy

8. Biopsy Devices Market, by Application

• 8.1. Introduction
• 8.2. Bone Marrow Biopsy
• 8.3. Breast Biopsy
• 8.4. Kidney Biopsy
• 8.5. Lung Biopsy
• 8.6. Prostate Biopsy

9. Biopsy Devices Market, by End User

• 9.1. Introduction
• 9.2. Academic & Research Institutes
• 9.3. Diagnostic & Imaging Centers
• 9.4. Hospitals

10. Americas Biopsy Devices Market

• 10.1. Introduction
• 10.2. Argentina
• 10.3. Brazil
• 10.4. Canada
• 10.5. Mexico
• 10.6. United States

11. Asia-Pacific Biopsy Devices Market

• 11.1. Introduction
• 11.2. Australia
• 11.3. China
• 11.4. India
• 11.5. Indonesia
• 11.6. Japan
• 11.7. Malaysia
• 11.8. Philippines
• 11.9. Singapore
• 11.10. South Korea
• 11.11. Taiwan
• 11.12. Thailand
• 11.13. Vietnam

12. Europe, Middle East & Africa Biopsy Devices Market

• 12.1. Introduction
• 12.2. Denmark
• 12.3. Egypt
• 12.4. Finland
• 12.5. France
• 12.6. Germany
• 12.7. Israel
• 12.8. Italy
• 12.9. Netherlands
• 12.10. Nigeria
• 12.11. Norway
• 12.12. Poland
• 12.13. Qatar
• 12.14. Russia
• 12.15. Saudi Arabia
• 12.16. South Africa
• 12.17. Spain
• 12.18. Sweden
• 12.19. Switzerland
• 12.20. Turkey
• 12.21. United Arab Emirates
• 12.22. United Kingdom

13. Competitive Landscape

• 13.1. Market Share Analysis, 2023
• 13.2. FPNV Positioning Matrix, 2023
• 13.3. Competitive Scenario Analysis
  • 13.3.1. LUMINELLE Announces China National Intellectual Property Administration's Decision to Grant Issuance of Patent for LUMINELLE Bx (Biopsy) System, Expanding Global Footprint
  • 13.3.2. Limaca Medical Receives FDA 510(k) Clearance for its Breakthrough Precision GI Endoscopic Biopsy Device
  • 13.3.3. Stryker Announces Commercial Launch of Q Guidance System with Cranial Guidance Software
  • 13.3.4. Merit Medical Acquires AngioDynamics' Catheter Portfolio and Biopsy System
  • 13.3.5. Argon's SuperCore Advantage Biopsy Instrument Launched in United States
  • 13.3.6. Quest Diagnostics to Acquire Haystack Oncology, Adding Sensitive Liquid Biopsy Technology for Improving Personalized Cancer Care to Oncology Portfolio
  • 13.3.7. Innovia Medical Launches the Oral Rotating Biopsy Punch at BACO International 2023
  • 13.3.8. Guardant360 CDx Gets FDA Approval as Companion Diagnostic for ORSERDU
  • 13.3.9. TransMed7, LLC Announces First Clinical Use of SpeedBird Breast Biopsy Devices for Commercial Launch
  • 13.3.10. Terumo India Partners with Argon Medical to Expand Portfolio

14. Competitive Portfolio

• 14.1. Key Company Profiles
• 14.2. Key Product Portfolio